Pharmaceutical

Nuntius partners with Taiho to develop mRNA cancer therapies

UK-based biotechnology company Nuntius Therapeutics has announced a strategic collaboration agreement with Japan’s Taiho Pharmaceutical to develop next-generation messenger ribonucleic acid (mRNA) cancer immunotherapies.

Aug 17, 2024 - 04:00
Nuntius partners with Taiho to develop mRNA cancer therapies
UK-based biotechnology company Nuntius Therapeutics has announced a strategic collaboration agreement with Japan’s Taiho Pharmaceutical to develop next-generation messenger ribonucleic acid (mRNA) cancer immunotherapies.
Read the original article

Tags:

Previous Article

The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies 

Next Article

AstraZeneca’s sBLA for LS-SCLC treatment gains FDA priority review

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Dec 13, 2024

To detect breast cancer sooner, an MIT professor designs an ultrasound bra

To detect breast cancer sooner, an MIT professor design...

Jul 28, 2023

Getting rid of bias in clinical calculators isn’t as simple as taking race out of the equation

Getting rid of bias in clinical calculators isn’t as si...

Jun 16, 2023